Affix Labs Secures €1 Million to Expand Sustainable Insect Repellent in Europe

Affix Labs Secures €1 Million for European Expansion



Affix Labs Group B.V., a Dutch Green Chemtech startup, has recently announced it raised €1 million in a funding round, primarily led by VP Capital and Oost NL. This substantial investment aims to accelerate the rollout of their flagship product, Repeltec, which is a revolutionary alternative to traditional insect repellents. The innovation arrives at a time when European pesticide regulations are becoming increasingly stringent, creating a favorable market for sustainable solutions.

The Innovation Behind Repeltec


The heart of Affix Labs' innovation is a proprietary formulation method that effectively dissolves oily, water-insoluble active ingredients into water-based systems. This formulation allows for the creation of a controlled-release layer, extending the product's efficacy to 12 weeks. Notably, Repeltec has undergone dermatological testing and is completely free of neurotoxic compounds that are prevalent in many traditional insect repellents. This makes it a safer option for consumers concerned about the health implications of chemicals in their household products.

Navigating Tightening Regulatory Landscapes


The regulatory climate in Europe regarding chemical pesticides is tightening. For example, Germany's forthcoming self-service ban, set to be implemented by 2025, will restrict a wide range of neurotoxic insecticides from retail shelves. Many other EU member states are expected to adopt similar measures, bolstering the demand for safer alternatives like Repeltec. Currently, Affix Labs holds active substance authorizations in key markets, including Germany, France, Austria, and Norway, highlighting the potential for significant market penetration.

Plans for Commercial Expansion and Partnerships


With the new funding secured, Affix Labs plans to expand its distribution channels across Germany, Austria, France, and Norway initially, with plans to penetrate the UK and Polish markets shortly thereafter. In addition to its consumer product lines, Affix Labs is launching a white-label B2B (Business to Business) model under the brand name “Powered by Affix Labs.” This initiative will enable fast-moving consumer goods (FMCG) companies, hospitality providers, and pest control manufacturers to integrate Affix’s pioneering technology into their own product ranges, enhancing their sustainability credentials while broadening their offerings.

About Affix Labs


Affix Labs is committed to revolutionizing the chemical industry by reducing dependency on traditional pesticides through innovative, eco-friendly solutions. Their patented solubility technology and controlled-release systems pave the way for establishing long-lasting, neurotoxic-free barriers against insects. As consumer preferences shift toward safer, more sustainable products, companies like Affix Labs are poised to play a critical role in transforming industry standards and practices.

For more information on Affix Labs and its innovative solutions, please visit their official website at affixlabs.com.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.